Location History:
- Boyds, MD (US) (2021 - 2023)
- Germantown, MD (US) (2022 - 2024)
- Blacksburg, VA (US) (2022 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: Inventor Spotlight: Rutul R. Shah
Introduction
Rutul R. Shah, based in Germantown, MD, is a prominent inventor with a remarkable track record of 13 patents. His contributions to the field of cancer therapy through innovative chimeric antigen receptors (CARs) have positioned him as a leader in advancing medical technologies.
Latest Patents
Among his recent innovations, Shah developed a patent for "ROR-1 specific chimeric antigen receptors and uses thereof." This patent details CARs designed specifically for cancer therapy, incorporating a single-chain variable fragment (scFv) from an anti-ROR-1 monoclonal antibody. The patent highlights immune effector cells containing these CARs, emphasizing methods for treating proliferative disorders. Another significant patent involves "Fusion constructs and methods of using thereof," which describes a fusion protein consisting of an antibody component and a second component, which may include a cytokine trap or an adenosine deaminase. This innovative approach includes applications in cancer treatment, showcasing the potential of combining various biological components for therapeutic benefit.
Career Highlights
Rutul Shah is presently employed at Precigen, Inc., where his expertise in biotechnology and immunotherapy drives significant advancements. His focus on integrating novel components in cancer therapy continues to generate impactful innovations that address complex medical challenges.
Collaborations
Shah collaborates with esteemed colleagues such as Helen Sabzevari and Peter Emtage. Together, they push boundaries in research and development, significantly contributing to the company's mission of pioneering transformative therapies.
Conclusion
Rutul R. Shah's continuous innovation in the field of biomedical science, particularly around cancer therapy, highlights his dedication to improving patient outcomes through advanced technology. With 13 patents to his name and ongoing contributions at Precigen, Inc., he is undoubtedly a significant figure in the landscape of modern medical inventions.